Interstitial Lung Disease Treatment

Interstitial Lung Disease Treatment: общие сведения

Interstitial lung disease (ILD) treatment in India depends on the exact ILD subtype, because inflammatory, fibrotic, autoimmune, exposure-related and drug-related lung diseases require different treatment strategies. The first priority is to establish the most likely diagnosis and determine whether the disease is stable, inflammatory, progressively fibrosing or already causing significant oxygen impairment.

Assessment is usually led by an ILD-focused pulmonologist and includes high-resolution CT (HRCT), pulmonary-function tests such as FVC and DLCO, oxygen saturation at rest and with exertion, and a detailed exposure and medicine history. Autoimmune testing is important when connective-tissue disease is possible. Selected patients may need bronchoscopy, multidisciplinary ILD review or lung biopsy when imaging and clinical findings do not provide a sufficiently confident diagnosis.

Treatment may include removal of a harmful exposure, corticosteroids or other immunomodulatory therapy for selected inflammatory ILDs, and antifibrotic medicines for appropriate progressive fibrotic disease. Pulmonary rehabilitation, vaccination, oxygen therapy and management of reflux, sleep-disordered breathing or other relevant conditions can support long-term care. Advanced disease may require lung-transplant assessment. Severe new breathlessness, rapidly falling oxygen levels, confusion or acute respiratory deterioration requires urgent local assessment rather than planned medical travel.

Cost in India depends on HRCT and pulmonary-function testing, autoimmune or other diagnostic investigations, medicines, oxygen requirements, rehabilitation and whether bronchoscopy, biopsy, hospital admission or transplant assessment is needed. Long-term antifibrotic therapy has a very different cost pathway from a diagnostic second opinion or a short course of treatment for inflammatory disease.

India has tertiary respiratory centres with pulmonologists, thoracic radiology, rheumatology collaboration, bronchoscopy, pulmonary rehabilitation and transplant referral pathways. Medical Help India is a connection platform that can connect medically stable international patients with an appropriate healthcare partner to review HRCT and lung-function trends, clarify the ILD subtype and provide an individual treatment and cost estimate.

Как это работает